Evaluation of Efficacy of Dellegra in Exposure Unit
NCT02175485
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Rhinitis Allergic
Interventions
DRUG:
Fexofenadine HCl 30 mg+Pseudophedrine HCl 60 mg
Sponsor
Sanofi